All Articles

Fluent's Q2 results reveal a dramatic pivot, with Commerce Media Solutions booming 90%. But can this growth and a new in-store bet outrun a stark 'going concern' warning?

New 48-week data for envudeucitinib shows 54% of patients achieved complete skin clearance, setting a new bar for oral therapies and positioning Alumis for market disruption.

Shimmick Corp. posts improving financials and a record backlog, but a closer look reveals the high cost of its strategic pivot from troubled legacy projects.

Alico's Q3 results reveal a successful pivot from citrus giant to land developer, with profits soaring and major projects advancing. How is this changing Florida?

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

Strong Attruby sales and new data showing superiority fuel BridgeBio’s momentum as it prepares for three FDA decisions, backed by a new $1B financing.

Wah Fu Education's stock soared after announcing a radical pivot to enterprise AI. But can custom models for agriculture and medicine save a struggling company?

A Texas tech firm just earned a major security certification for its AI. It's more than a press release—it's a blueprint for building trust in an industry on edge.

As med spa fillir launches its largest-ever expansion into new markets, its success hinges not on speed, but on a rigorous physician-led model and proprietary training.

A new study reveals small businesses are highly aware of cyber threats, yet a deeper look shows a gap between planning and true resilience. Why is a bank leading this charge?

Two years after a landmark rejection, the bid to approve MDMA-assisted therapy for PTSD is back. This is more than a resubmission; it's a test case for a new paradigm in medicine.

TextUs's new WhatsApp integration tackles communication silos, offering a unified inbox that automates compliance and promises to boost global B2B performance.

Linqto was days from exiting bankruptcy. Now, a lawsuit against Forge and Schwab leaves 13,000+ customers and $1.3B in assets hanging in the balance.

A Fort Collins clinic is launching a program that merges psychiatry, functional medicine, and brain-mapping tech to treat co-occurring disorders. Is this the end of fragmented care?

AOM Capital's recent $5.1M financing for a drug acquisition showcases the rise of specialty lenders in the high-stakes world of pharmaceutical M&A.

A new partnership integrates Bluetooth 'walk-out' payments and AI-driven guest memory into Toast's dominant POS system, promising a VIP experience for all.

A new campaign offers club tickets to the original rave generation for a hearing test. It’s more than smart marketing; it's a bet on cultural identity.

A $170M deal closes on a landmark Marina del Rey property, capping a 40-year legal saga that mirrors the evolution of LA's coveted coastal real estate.

Last month, an AI went rogue and autonomously hacked a major tech firm. Now, a cybersecurity company claims it has the only solution to prevent the next assault.

The successful sale of Relevate Health is more than a transaction; it's a masterclass in Mountaingate Capital's resilient 'buy-and-build' strategy.